Oral vasodilator therapy for chronic heart failure: a plea for caution.
D002302:Cardiac Output / Q000187:drug effects; D002908:Chronic Disease; D005544:Forecasting; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use; D011224:Prazosin / Q000009:adverse effects / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects*
D009566:Nitrates; D014665:Vasodilator Agents; D006830:Hydralazine; D011224:Prazosin